Follistatin 344 Dosage, Reconstitution & Mixing Trends | World Peptide Association

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 1 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 1 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Follistatin-344 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Rotate injection sites immediately and reduce injection frequency temporarily to allow tissue recovery. Minor redness lasting 2–4 hours post-injection is normal; persistent swelling or pain suggests either improper technique (injecting too quickly, not allowing alcohol to dry) or sensitivity to bacteriostatic water preservatives. Switch to sterile water for reconstitution if benzyl alcohol sensitivity is suspected, but note that sterile water reduces storage stability to 7–10 days refrigerated. Never inject into visibly irritated or inflamed tissue. This reduces absorption and increases infection risk.

Discard it immediately. Cloudiness or visible particles indicate protein aggregation. The amino-acid chain has unfolded and precipitated out of solution. This occurs when bacteriostatic water pH is incorrect, when the vial was shaken instead of swirled, or when the peptide was exposed to temperatures above 8°C. Aggregated peptide has no binding affinity for myostatin and will not produce measurable effects. Never attempt to 'clarify' cloudy solution by heating, filtering, or adding additional solvent. The peptide is already denatured.

Verify injection technique first. Subcutaneous administration requires 45-degree needle angle and injection into adipose tissue, not muscle. If technique is correct, consider switching to intramuscular administration for faster systemic absorption, or increase dose frequency to twice daily while keeping total daily amount constant. Slow absorbers. Common in models with higher body fat percentage. May need IM dosing to achieve target plasma levels.

Yes, transient dose escalation to 300–400 mcg on resistance training days is supported by the myostatin rebound mechanism. Myostatin expression temporarily spikes 12–24 hours after eccentric-heavy exercise as part of the muscle damage response. Administering a higher follistatin dose within this window suppresses the myostatin surge that would otherwise blunt protein synthesis during recovery. On non-training days, return to baseline dosing (150–250 mcg) to minimize activin binding without sacrificing myostatin suppression.